The University of Chicago Header Logo

Jennifer L. McNeer

Concepts (182)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
2022
394
3.840
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
2019
51
1.470
Why?
Hematologic Diseases
3
2017
78
1.130
Why?
Immunotherapy
2
2020
689
0.950
Why?
Hematopoietic Stem Cell Transplantation
4
2019
891
0.940
Why?
Central Nervous System Diseases
1
2022
52
0.790
Why?
Central Nervous System Neoplasms
1
2022
85
0.740
Why?
Ploidies
1
2019
41
0.650
Why?
Child
16
2022
7197
0.610
Why?
Antineoplastic Agents, Immunological
1
2020
202
0.600
Why?
Immunoglobulins, Intravenous
1
2017
65
0.540
Why?
Lymphoma, Non-Hodgkin
1
2018
261
0.510
Why?
Immune System Diseases
1
2015
27
0.490
Why?
Adolescent
18
2022
9288
0.490
Why?
Burkitt Lymphoma
1
2014
32
0.460
Why?
Kruppel-Like Transcription Factors
1
2014
100
0.440
Why?
Oxides
2
2010
43
0.430
Why?
Arsenicals
2
2010
48
0.430
Why?
Young Adult
16
2021
6347
0.420
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2022
2567
0.410
Why?
Folic Acid
1
2011
63
0.380
Why?
Carnitine
2
2021
14
0.350
Why?
MAP Kinase Kinase Kinases
1
2010
42
0.350
Why?
Asparaginase
2
2021
35
0.350
Why?
Child, Preschool
8
2019
3743
0.340
Why?
Humans
33
2022
89621
0.340
Why?
Chemical and Drug Induced Liver Injury
2
2021
66
0.330
Why?
Communicable Diseases
1
2010
63
0.330
Why?
Injections, Spinal
2
2022
45
0.330
Why?
C-Reactive Protein
1
2010
192
0.320
Why?
Antineoplastic Agents
5
2021
2415
0.320
Why?
Infant
5
2019
3167
0.300
Why?
Glucocorticoids
1
2010
358
0.300
Why?
Biomarkers, Tumor
3
2021
1555
0.290
Why?
Polyethylene Glycols
2
2021
359
0.290
Why?
Polymorphism, Genetic
1
2011
826
0.290
Why?
Neoplasms
3
2020
3079
0.280
Why?
Remission Induction
5
2019
740
0.270
Why?
Translocation, Genetic
2
2016
266
0.230
Why?
Male
18
2021
42558
0.220
Why?
Neoplasm Recurrence, Local
2
2021
1366
0.220
Why?
Prognosis
4
2020
3796
0.210
Why?
Female
18
2021
46354
0.210
Why?
Leukemia, B-Cell
1
2022
23
0.200
Why?
Etoposide
2
2019
206
0.190
Why?
Methotrexate
1
2022
250
0.190
Why?
Cytogenetic Analysis
2
2019
71
0.190
Why?
Survivors
2
2020
234
0.180
Why?
Retrospective Studies
5
2022
9089
0.180
Why?
Neoplasm, Residual
2
2019
181
0.170
Why?
Postoperative Complications
1
2010
2286
0.170
Why?
Hematologic Neoplasms
2
2016
343
0.170
Why?
Anthracyclines
1
2019
38
0.160
Why?
Infant, Newborn
3
2019
2487
0.160
Why?
Disease-Free Survival
2
2019
1217
0.160
Why?
Leukemia, Myeloid, Acute
2
2019
797
0.160
Why?
Recurrence
1
2022
1144
0.160
Why?
Leukemia
1
2021
323
0.160
Why?
Hyperbilirubinemia
1
2018
21
0.150
Why?
Cancer Survivors
1
2020
95
0.150
Why?
Adult
12
2021
26694
0.150
Why?
Risk Factors
3
2020
5516
0.150
Why?
Mediastinal Neoplasms
1
2017
47
0.140
Why?
Salvage Therapy
1
2018
236
0.140
Why?
Treatment Outcome
5
2018
8273
0.140
Why?
Point-of-Care Systems
1
2017
147
0.140
Why?
Prevalence
2
2018
1246
0.140
Why?
Chronic Disease
1
2020
950
0.140
Why?
Chemotherapy-Induced Febrile Neutropenia
1
2016
6
0.130
Why?
Blood Culture
1
2016
10
0.130
Why?
Hodgkin Disease
1
2017
181
0.130
Why?
Escherichia coli Infections
1
2016
35
0.130
Why?
Bone Marrow Examination
1
2015
47
0.130
Why?
Radiotherapy
1
2017
334
0.130
Why?
Philadelphia Chromosome
1
2015
41
0.130
Why?
Imatinib Mesylate
1
2015
127
0.120
Why?
Bacteremia
1
2016
102
0.120
Why?
Survival Rate
4
2021
1909
0.120
Why?
Drug Resistance, Neoplasm
1
2018
618
0.120
Why?
Prednisone
2
2017
259
0.120
Why?
Guideline Adherence
1
2016
232
0.120
Why?
U937 Cells
2
2010
32
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2016
486
0.110
Why?
Escherichia coli
1
2016
606
0.110
Why?
Chromosome Aberrations
1
2014
390
0.110
Why?
Protein-Tyrosine Kinases
1
2014
309
0.110
Why?
Leukemia, T-Cell
1
2012
17
0.100
Why?
Stress, Psychological
1
2016
321
0.100
Why?
Antibodies, Monoclonal, Humanized
1
2018
972
0.100
Why?
Pediatrics
1
2017
357
0.100
Why?
Intracellular Signaling Peptides and Proteins
1
2014
387
0.100
Why?
Lymphoma, T-Cell
1
2012
55
0.100
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2012
105
0.100
Why?
Transplantation, Homologous
2
2012
997
0.090
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
54
0.090
Why?
Dithiothreitol
1
2010
25
0.090
Why?
Biomarkers
2
2022
1770
0.090
Why?
Acetylcysteine
1
2010
70
0.080
Why?
Tretinoin
1
2010
128
0.080
Why?
Area Under Curve
1
2010
337
0.080
Why?
Fusion Proteins, bcr-abl
2
2022
108
0.080
Why?
Quality of Life
1
2017
1673
0.080
Why?
Protein Kinases
1
2010
213
0.080
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2010
173
0.080
Why?
Enzyme Activation
1
2010
698
0.080
Why?
Autophagy
1
2010
159
0.080
Why?
Drug Administration Schedule
1
2010
895
0.080
Why?
Dexamethasone
1
2010
344
0.080
Why?
RNA, Small Interfering
1
2010
557
0.080
Why?
Hematopoietic Stem Cells
1
2010
301
0.070
Why?
Transplantation Conditioning
1
2010
374
0.070
Why?
Age Factors
1
2012
1874
0.070
Why?
Graft vs Host Disease
1
2010
360
0.070
Why?
Proportional Hazards Models
1
2010
856
0.070
Why?
ROC Curve
1
2010
780
0.070
Why?
Phosphorylation
1
2010
1134
0.070
Why?
Reactive Oxygen Species
1
2010
490
0.070
Why?
Induction Chemotherapy
2
2021
152
0.070
Why?
Sex Factors
1
2010
1068
0.070
Why?
Predictive Value of Tests
1
2010
1728
0.060
Why?
Cell Line, Tumor
1
2010
2565
0.060
Why?
Genetic Variation
1
2010
1380
0.050
Why?
Mucin-4
1
2022
7
0.050
Why?
Prospective Studies
2
2021
4310
0.050
Why?
Amino Acid Sequence
2
2016
2063
0.050
Why?
Base Sequence
2
2016
2329
0.050
Why?
United States
3
2021
7020
0.050
Why?
Pediatric Obesity
1
2021
26
0.050
Why?
Acute Disease
1
2022
842
0.040
Why?
Molecular Targeted Therapy
1
2021
286
0.040
Why?
Feasibility Studies
1
2021
783
0.040
Why?
Liver Function Tests
1
2018
92
0.040
Why?
Survival Analysis
1
2021
1535
0.040
Why?
Immunohistochemistry
1
2022
1801
0.040
Why?
Vincristine
1
2017
112
0.040
Why?
Vinblastine
1
2017
108
0.040
Why?
Bleomycin
1
2017
102
0.040
Why?
Chromosome Breakpoints
1
2016
15
0.040
Why?
Dacarbazine
1
2017
102
0.040
Why?
Cyclophosphamide
1
2017
302
0.030
Why?
Needs Assessment
1
2017
157
0.030
Why?
Doxorubicin
1
2017
303
0.030
Why?
Disease Progression
1
2021
1492
0.030
Why?
Oncologists
1
2016
36
0.030
Why?
Longitudinal Studies
1
2020
1076
0.030
Why?
Patient Reported Outcome Measures
1
2017
192
0.030
Why?
Combined Modality Therapy
1
2020
1720
0.030
Why?
Marital Status
1
2016
42
0.030
Why?
Ultrasonography
1
2018
712
0.030
Why?
Educational Status
1
2016
195
0.030
Why?
Sequence Analysis, RNA
1
2016
236
0.030
Why?
Interviews as Topic
1
2016
344
0.030
Why?
Cohort Studies
1
2021
2878
0.030
Why?
Oncogene Proteins, Fusion
1
2014
133
0.030
Why?
Anxiety
1
2016
311
0.030
Why?
Pilot Projects
1
2016
873
0.030
Why?
Liver
1
2018
1210
0.030
Why?
Follow-Up Studies
1
2020
3671
0.030
Why?
Genes, myc
1
2012
40
0.030
Why?
Chromosomes, Human, Pair 14
1
2012
49
0.030
Why?
Chromosomes, Human, Pair 8
1
2012
84
0.030
Why?
Neoplasm Staging
1
2017
2023
0.020
Why?
Depression
1
2016
509
0.020
Why?
Clinical Laboratory Techniques
1
2012
76
0.020
Why?
World Health Organization
1
2012
107
0.020
Why?
Incidence
1
2016
1598
0.020
Why?
Immunophenotyping
1
2012
217
0.020
Why?
Time Factors
1
2020
5344
0.020
Why?
Bone Marrow Cells
1
2012
262
0.020
Why?
Ubiquitin-Activating Enzymes
1
2010
6
0.020
Why?
Autophagy-Related Protein 7
1
2010
12
0.020
Why?
Beclin-1
1
2010
15
0.020
Why?
Cross-Sectional Studies
1
2016
1719
0.020
Why?
Severity of Illness Index
1
2016
1847
0.020
Why?
MAP Kinase Signaling System
1
2010
199
0.020
Why?
Apoptosis Regulatory Proteins
1
2010
198
0.020
Why?
Microtubule-Associated Proteins
1
2010
184
0.020
Why?
Mice, Knockout
1
2010
2003
0.020
Why?
Membrane Proteins
1
2010
1225
0.010
Why?
Aged
1
2021
19237
0.010
Why?
Mice
1
2010
11792
0.010
Why?
Animals
1
2010
27426
0.010
Why?
McNeer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (182)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_